Henan Lingrui Pharmaceutial Co., Ltd. Class ASSE: 600285

Announcement on Convening the Q3 2025 Performance Briefing

· Issued by Henan Lingrui Pharmaceutial Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Convening the Q3 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment